Cargando…
Evaluation of Diabetes Care parameters in capillary blood collected with a novel sampling device
The aim of this study was to determine whether the Hem-Col method of obtaining and storing blood is an acceptable alternative to venepuncture for measuring Diabetes Care parameters. Design and methods: Hem-Col is a novel blood collection device that is designed to collect capillary blood drawn with...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804795/ https://www.ncbi.nlm.nih.gov/pubmed/31649987 http://dx.doi.org/10.1016/j.plabm.2019.e00135 |
_version_ | 1783461270529245184 |
---|---|
author | Huijskens, M.J.A.J. Castel, R. Vermeer, H.J. Verheijen, F.M. |
author_facet | Huijskens, M.J.A.J. Castel, R. Vermeer, H.J. Verheijen, F.M. |
author_sort | Huijskens, M.J.A.J. |
collection | PubMed |
description | The aim of this study was to determine whether the Hem-Col method of obtaining and storing blood is an acceptable alternative to venepuncture for measuring Diabetes Care parameters. Design and methods: Hem-Col is a novel blood collection device that is designed to collect capillary blood drawn with a finger prick. Hem-Col is a microtube containing an anticoagulant and a preservation buffer to enhance analyte stability in whole blood. The Diabetes Care parameters cholesterol, creatinine, HbA1c, high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, and triglycerides were measured both in blood/plasma collected via Hem-Col and blood/plasma collected with venepuncture. The results were compared to assess the agreement between the two methods. Results: HbA1c shows agreement after storage for up to 120 hours at temperatures ranging from 4 to 37 °C. Cholesterol, HDL cholesterol, LDL cholesterol, triglycerides and creatinine can be measured after 120 hours of storage in Hem-Col buffer, if high temperatures are avoided, and with the use of correction factors or adaptations to reported reference intervals. Conclusion: Hem-Col is suitable for the measurement of HbA1c after storage for up to 120 hours at temperatures ranging from 4 to 37 °C. Cholesterol, creatinine, HDL cholesterol, LDL cholesterol and triglycerides can be measured after 120 hours of storage in Hem-Col buffer, if high temperatures are avoided. Further studies are required to determine whether Hem-Col can replace the venepuncture for the Diabetes Care parameters. |
format | Online Article Text |
id | pubmed-6804795 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-68047952019-10-24 Evaluation of Diabetes Care parameters in capillary blood collected with a novel sampling device Huijskens, M.J.A.J. Castel, R. Vermeer, H.J. Verheijen, F.M. Pract Lab Med Article The aim of this study was to determine whether the Hem-Col method of obtaining and storing blood is an acceptable alternative to venepuncture for measuring Diabetes Care parameters. Design and methods: Hem-Col is a novel blood collection device that is designed to collect capillary blood drawn with a finger prick. Hem-Col is a microtube containing an anticoagulant and a preservation buffer to enhance analyte stability in whole blood. The Diabetes Care parameters cholesterol, creatinine, HbA1c, high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, and triglycerides were measured both in blood/plasma collected via Hem-Col and blood/plasma collected with venepuncture. The results were compared to assess the agreement between the two methods. Results: HbA1c shows agreement after storage for up to 120 hours at temperatures ranging from 4 to 37 °C. Cholesterol, HDL cholesterol, LDL cholesterol, triglycerides and creatinine can be measured after 120 hours of storage in Hem-Col buffer, if high temperatures are avoided, and with the use of correction factors or adaptations to reported reference intervals. Conclusion: Hem-Col is suitable for the measurement of HbA1c after storage for up to 120 hours at temperatures ranging from 4 to 37 °C. Cholesterol, creatinine, HDL cholesterol, LDL cholesterol and triglycerides can be measured after 120 hours of storage in Hem-Col buffer, if high temperatures are avoided. Further studies are required to determine whether Hem-Col can replace the venepuncture for the Diabetes Care parameters. Elsevier 2019-09-19 /pmc/articles/PMC6804795/ /pubmed/31649987 http://dx.doi.org/10.1016/j.plabm.2019.e00135 Text en © 2019 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Huijskens, M.J.A.J. Castel, R. Vermeer, H.J. Verheijen, F.M. Evaluation of Diabetes Care parameters in capillary blood collected with a novel sampling device |
title | Evaluation of Diabetes Care parameters in capillary blood collected with a novel sampling device |
title_full | Evaluation of Diabetes Care parameters in capillary blood collected with a novel sampling device |
title_fullStr | Evaluation of Diabetes Care parameters in capillary blood collected with a novel sampling device |
title_full_unstemmed | Evaluation of Diabetes Care parameters in capillary blood collected with a novel sampling device |
title_short | Evaluation of Diabetes Care parameters in capillary blood collected with a novel sampling device |
title_sort | evaluation of diabetes care parameters in capillary blood collected with a novel sampling device |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804795/ https://www.ncbi.nlm.nih.gov/pubmed/31649987 http://dx.doi.org/10.1016/j.plabm.2019.e00135 |
work_keys_str_mv | AT huijskensmjaj evaluationofdiabetescareparametersincapillarybloodcollectedwithanovelsamplingdevice AT castelr evaluationofdiabetescareparametersincapillarybloodcollectedwithanovelsamplingdevice AT vermeerhj evaluationofdiabetescareparametersincapillarybloodcollectedwithanovelsamplingdevice AT verheijenfm evaluationofdiabetescareparametersincapillarybloodcollectedwithanovelsamplingdevice |